Literature DB >> 9591937

Rifaximin systemic absorption in patients with ulcerative colitis.

F Rizzello, P Gionchetti, A Venturi, M Ferretti, S Peruzzo, X Raspanti, M Picard, N Canova, E Palazzini, M Campieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9591937     DOI： 10.1007/s002280050426

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  A meta-analysis of antibiotic therapy for active ulcerative colitis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

2.  In vitro activity and fecal concentration of rifaximin after oral administration.

Authors:  Z D Jiang; S Ke; E Palazzini; L Riopel; H Dupont
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 3.  Rifaximin: a review of its use in the management of traveller's diarrhoea.

Authors:  Gayle W Robins; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  The effect of rifaximin on gut flora and Staphylococcus resistance.

Authors:  Mi-Sung Kim; Walter Morales; Andres Ardila Hani; Sharon Kim; Gene Kim; Stacy Weitsman; Christopher Chang; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

5.  Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.

Authors:  David N Taylor; Robin McKenzie; Anna Durbin; Colleen Carpenter; Robert Haake; A Louis Bourgeois
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

6.  The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.

Authors:  Hoonmo L Koo; Herbert L Dupont; David B Huang
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

7.  Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.

Authors:  Ji Young Chang; Seong-Eun Kim; Tae Hun Kim; So-Youn Woo; Min Sun Ryu; Yang-Hee Joo; Ko Eun Lee; Jihyun Lee; Kang Hoon Lee; Chang Mo Moon; Hye-Kyung Jung; Ki-Nam Shim; Sung-Ae Jung
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.